Blog

Home/News/Japan’s Fujifilm to spend $928 million to double capacity of Danish drug facility

Japan’s Fujifilm to spend $928 million to double capacity of Danish drug facility

Fujifilm Holdings Corp will spend $928 million to double capacity at a drug manufacturing facility in Denmark, which it has pledged to use in producing COVID-19 treatments, as the Japanese company steps up its pivot towards healthcare.

    

Written by

Peter Zirbes, ESQ. A Full Service Law Office 718 544 6300